Wolverine Trading, LLC Curis Inc Put Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$2.31 - $5.13 $4,389 - $9,747	-1,900 Reduced 14.62%	11,100 $28,000
Q4 2021 Feb 14, 2022	SELL	$4.45 - $8.09 $17,355 - $31,551	-3,900 Reduced 23.08%	13,000 $62,000
Q3 2021 Nov 12, 2021	SELL	$6.94 - $8.85 $204,730 - $261,075	-29,500 Reduced 63.58%	16,900 $131,000
Q2 2021 Aug 06, 2021	BUY	$7.45 - $16.27 $43,210 - $94,366	5,800 Added 14.29%	46,400 $346,000
Q1 2021 May 14, 2021	SELL	$8.78 - $12.8 $33,364 - $48,640	-3,800 Reduced 8.56%	40,600 $463,000
Q4 2020 Feb 12, 2021	BUY	$1.08 - $8.2 $47,952 - $364,079	44,400 New	44,400 $347,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.